Hironori Ninomiya

Hironori Ninomiya

Japanese Foundation for Cancer Research - Tokyo / Japan
Medical and Health Sciences / Pathology
AD Scientific Index ID: 4516617
財団法人がん研究振興財団
person_outline Hironori Ninomiya's MOST POPULAR ARTICLES
1-) RET, ROS1 and ALK fusions in lung cancerK Takeuchi, M Soda, Y Togashi, R Suzuki, S Sakata, S Hatano, R Asaka, ...Nature medicine 18 (3), 378-381, 201214312012
2-) EML4-ALK fusion is linked to histological characteristics in a subset of lung cancersK Inamura, K Takeuchi, Y Togashi, K Nomura, H Ninomiya, M Okui, ...Journal of thoracic oncology 3 (1), 13-17, 20085532008
3-) EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onsetK Inamura, K Takeuchi, Y Togashi, S Hatano, H Ninomiya, N Motoi, ...Modern Pathology 22 (4), 508-515, 20095272009
4-) P-glycoprotein mediates ceritinib resistance in anaplastic lymphoma kinase-rearranged non-small cell lung cancerR Katayama, T Sakashita, N Yanagitani, H Ninomiya, A Horiike, ...EBioMedicine 3, 54-66, 20161632016
5-) Is the epidermal growth factor receptor status in lung cancers reflected in clinicopathologic features?K Inamura, H Ninomiya, Y Ishikawa, O MatsubaraArchives of pathology & laboratory medicine 134 (1), 66-72, 20101442010